Prescription abandonment climbs sharply as out-of-pocket costs rise, and prior authorization delays push more patients away. Showing cost and coverage at the point of prescribing could change whether patients ever start therapy.
News|Videos|December 3, 2024
GLP-1 RA antiobesity medications: Long-term safety
Author(s)Richard Payerchin
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
Advertisement
GLP-1 RA drugs seem like
Advertisement
Related to this article
Why advance directive conversations should not wait for the emergency department
Unfilled prescriptions and skipped referrals often reflect hidden logistical, financial and emotional work, not a lack of motivation. A behavioral scientist explains where patients drop off and how practices can close the gap in the first days after a recommendation.
If Medicare cuts surgeon pay, it does not follow that Medicare should also cut reimbursement for primary care.
In three online experiments, adults who would have to pay for a procedure out of pocket were less likely to schedule it, and the anxiety the cost caused raised the pain they expected.
Dengue is no longer just a travel disease in parts of Florida. Here’s how to test, treat and report it.
Protecting patient health information may be easier than you think. Here's a working checklist to start for your practice's website.
HFMA proposes ‘Declaration on Healthcare Affordability and Sustainability’ as physicians and patients feel the squeeze.
Advertisement
Advertisement
Trending on Medical Economics
1
The states where physician noncompetes can still be enforced in 2026
2
82% of Americans back a law requiring human review of AI claim denials, survey finds
3
Blue Cross and Blue Shield of Texas leaves Medicare Advantage as UnitedHealthcare splits with Florida health systems
4
Medically frail or not? A court ruling on Medicaid scrambles the answer for physicians, regulators
5